
The leadership changes signal accelerated expansion and deeper integration of palliative‑care services, positioning firms to capture growing consumer demand and value‑based reimbursement models.
The hospice and palliative‑care sector is experiencing a wave of executive reshuffling as providers seek to scale operations and capture a rapidly expanding market. Mettle Health’s creation of a Chief Growth Officer underscores the shift toward consumer‑direct models that rely on strategic partnerships and outreach beyond traditional health‑system referrals. By hiring Camille Borgo, a veteran of network medical affairs at UCSF, the company aims to increase awareness of its suite of services—advance care planning, bereavement counseling, and spiritual support—targeting families who often remain unaware of available resources.
Regional operators are also bolstering leadership to navigate private‑equity involvement and multi‑state growth. Legacy Hospice’s appointment of Elaine Ziegler, a former private‑equity advisor with extensive hospice division experience, follows two successful recapitalizations and positions the organization to deepen its footprint across the Southeast. Similarly, Island Hospice’s selection of Patricia Pancner, who brings operational expertise from Bristol Hospice and Kindred at Home, reinforces its commitment to scaling care delivery for over 10,000 patients while maintaining a volunteer‑driven community model.
Technology‑focused firms are equally prioritizing clinical leadership to accelerate value‑based care. Vynca’s new chief medical officer, Dr. Jill Schwartz‑Chevlin, brings two decades of home‑based, payer‑aligned experience, crucial for integrating predictive‑analytics software with palliative‑care pathways. Her track record of cutting hospital utilization by 40 % at WellBe Senior Medical signals Vynca’s intent to reduce costly acute care episodes while expanding access to community‑based palliative services. Collectively, these appointments highlight an industry trend toward combining seasoned leadership with innovative delivery models to meet rising demand for high‑quality, cost‑effective end‑of‑life care.
Comments
Want to join the conversation?
Loading comments...